ArticlesAbstractPharmacognosy Research,2019,11,3,267-272.DOI:10.4103/pr.pr_161_18Published:August 2019Authors:Arjun Singh, Himanshu Sharma, Ravinder Singh, and Narayanam Srikanth Author(s) affiliations:Arjun Singh, Himanshu Sharma, Ravinder Singh, Narayanam Srikanth Department of Chemistry, Central Council for Research in Ayurvedic Sciences, New Delhi, India. Abstract:Background: Qualitative and quantitative marker estimation is the quality basis of Ayurvedic pharmaceuticals. Boerhavia diffusa is a widely used herb in the Indian system of medicine. Objective: Estimation of boeravinone-B in hydroalcoholic extract of raw drug (ingredient) as well as its poly-herbal formulation to authenticate ingredients ratio in finished product by high-performance thin layer chromatography (HPTLC) method. Materials and Methods: Based on planar chromatographic method (HPTLC) with optimized mobile phase toluene: ethyl acetate: formic acid: methanol (5:3:1:1 v/v). Further densitometry and marker quantification of developed plate were carried out at ultraviolet 254 nm. Results: Presented in the form of comparative characteristic HPTLC fingerprints and densitograms with well‑resolved prominent bands for boeravinone‑B at retardation factor (Rf) – 0.87 in both the samples. The linear regression by calibration plots revealed good linear relationship with 0.99953 with standard deviation 0.74% with respect to the area in the concentration range of 200–1000 ng/spot. Statistical analysis proves that the developed quantification method is reproducible and selective. Findings showed the presence of 0.055% and 0.012% w/w boeravinone‑B in hydroalcoholic extract of B. diffusa and its polyherbal formulation, respectively, at Rf 0.87 under λ 254 nm. Conclusion: The study established fast, simple, precise, and cost‑effective methods for qualitative and quantitative studies of Ayurvedic raw drugs, and polyherbal formulations consist of B. diffusa. It estimated boeravinone‑B in raw drug (ingredient) as well as in its polyherbal formulation. The study qualitatively and quantitatively authenticated the presence and ratio of B. diffusa in polyherbal dosage form (capsule). Moreover, it suggested that the plant contains rich amount of boeravinone‑B; this may be directed in selection of genuine plant species in formulation development as well as in standardization. Keywords:Boeravinone‑B, Boerhavia diffusa, Densitometry, High‑performance thin‑layer chromatography, Polyherbal formulation.View:PDF (3.11 MB) PDF Thumbnails Document Outline Search Document Find Toggle Sidebar Previous Next Page: Fullscreen Print Download Current View Zoom Out Zoom In Automatic Zoom Actual Size Fit Page Full Width 50% 75% 100% 125% 150% 200% More Information Less Information Close Click here to download the PDF file. Images High‑Performance Thin‑Layer Chromatography Estimation of Boeravinone‑B in Boerhavia diffusa L. and its Polyherbal Dosage Form (Capsule) KeywordsBoeravinone‑BBoerhavia diffusaDensitometryHigh‑performance thin‑layer chromatographyPolyherbal formulation. ‹ Neuroprotective and Anti‑inflammatory Activities of Aegiceras corniculatum (L.) Blanco up Alpha Glucosidase Inhibiting Activity and in vivo Antidiabetic Activity of Fraxinus floribunda Bark in Streptozotocin‑Induced Diabetic Rats ›